effect of hyalorunidase and steroid epidural injection in lumbar spinal stenosis treatment

Not Applicable

Conditions: umbosacral spinal stenosis.
Spinal stenosis, lumbar region
M48.06

Registration Number: IRCT20171106037267N2

Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 30

Inclusion Criteria

Patients with lumbosacral spinal stenosis who have pain and other clinical symptoms didn’t respond to conservative management
Age between 45 to 75 y/o
Complete and sign constent form Exclusion

Exclusion Criteria

Diabetes mellitus
Rheumatologic disease such as collagen vascular disease , SLE , gout
Simultaneous radiculopathy
Simultaneous neuropathy
Brucella infection
BMI> 42
Knee arthroplasty in affected side
Coaglopathy
Inability to complete questionnaire and poor cooperation
Allergy to medication
Hepatic , renal or cardiac failure
Pregnancy
Cancer
Patients who are receiving Anticoagulant

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient's pain. Timepoint: Before injection , 2, 4 and 8 weeks after injection. Method of measurement: Visual Analogue Scale , Quebec back pain disability scale and Oswestry disability index questionnaire.;Functional improvement. Timepoint: Before injection , 2, 4 and 8 weeks after injection. Method of measurement: Quebec back pain disability scale and Oswestry disability index questionnaire.

Secondary Outcome Measures

Name	Time	Method
?Quality of life improvement. Timepoint: Befor injection , 2, 4 and 8 weeks after injection. Method of measurement: Quebec back pain disability scale and Oswestry disability index questionnaire.;Decrease analgesic usage. Timepoint: Before injection , 2, 4 and 8 weeks after injection. Method of measurement: Visual Analogue Scale.